MIVTUFLY

What this means for you

Not registered yet, but its 13 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97631024

Mark type

Stylized text

Filed

13 Oct 2022

Published for opposition

22 Aug 2023

Attorney of record

Yana Gorbach

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for treatment of dermatomyositis

Owner

• Pfizer Inc., New York, NY, US
• Pfizer Inc., New York, NY, US

Prosecution history

• 18 Mar 2026 — SOU TEAS EXTENSION RECEIVED
• 30 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
• 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 26 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 25 Aug 2025 — SOU EXTENSION 4 GRANTED
• 25 Aug 2025 — SOU EXTENSION 4 FILED
• 25 Aug 2025 — SOU TEAS EXTENSION RECEIVED
• 20 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 20 Mar 2025 — SOU EXTENSION 3 GRANTED
• 19 Mar 2025 — SOU EXTENSION 3 FILED
• 19 Mar 2025 — SOU TEAS EXTENSION RECEIVED
• 21 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 21 Sept 2024 — SOU EXTENSION 2 GRANTED